Complement activation is a key feature in MS plaques, as studies have revealed that NAWM plaques were positive from complement proteins (e.g., C3, C1q), activation products (e.g., C3b, C4d), and various regulators (e.g., factor H) [98,99]. Here, C3 is linked to myeloid sarcoma.